Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Delayed recruiting of TPD52 to lipid droplets - evidence for a "second wave" of lipid droplet-associated proteins that respond to altered lipid storage induced by Brefeldin A treatment.

Chen Y, Frost S, Khushi M, Cantrill LC, Yu H, Arthur JW, Bright RK, Groblewski GE, Byrne JA.

Sci Rep. 2019 Jul 5;9(1):9790. doi: 10.1038/s41598-019-46156-1.

2.

"I remember how I felt, but I don't remember the gene": Families' experiences of cancer-related genetic testing in childhood.

McGill BC, Wakefield CE, Vetsch J, Lim Q, Warby M, Metcalfe A, Byrne JA, Cohn RJ, Tucker KM.

Pediatr Blood Cancer. 2019 Aug;66(8):e27762. doi: 10.1002/pbc.27762. Epub 2019 Apr 22.

PMID:
31006986
3.

Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool.

Labbé C, Grima N, Gautier T, Favier B, Byrne JA.

PLoS One. 2019 Mar 1;14(3):e0213266. doi: 10.1371/journal.pone.0213266. eCollection 2019.

4.

The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions.

Byrne JA, Grima N, Capes-Davis A, Labbé C.

Biomark Insights. 2019 Feb 5;14:1177271919829162. doi: 10.1177/1177271919829162. eCollection 2019. Review.

5.

Research Perspective on Utilizing and Valuing Tumor Biobanks.

Rush A, Matzke L, Cooper S, Gedye C, Byrne JA, Watson PH.

Biopreserv Biobank. 2019 Jun;17(3):219-229. doi: 10.1089/bio.2018.0099. Epub 2018 Dec 21.

PMID:
30575428
6.

Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.

Sylvester DE, Chen Y, Jamieson RV, Dalla-Pozza L, Byrne JA.

J Med Genet. 2018 Dec;55(12):785-793. doi: 10.1136/jmedgenet-2018-105488. Epub 2018 Oct 4.

PMID:
30287599
7.

Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.

Bull LN, Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Dodge JL, Emerick K, Wanty C, Wali S, Blanchard S, Lacaille F, Byrne JA, van Eerde AM, Kolho KL, Houwen R, Lobritto S, Hupertz V, McClean P, Mieli-Vergani G, Sokal E, Rosenthal P, Whitington PF, Pawlowska J, Thompson RJ.

Hepatol Commun. 2018 Mar 30;2(5):515-528. doi: 10.1002/hep4.1168. eCollection 2018 May.

8.

Comparison of general anaesthesia and non-general anaesthesia approach in transfemoral transcatheter aortic valve implantation.

Eskandari M, Aldalati O, Dworakowski R, Byrne JA, Alcock E, Wendler O, MacCarthy PA, Ludman PF, Hildick-Smith DJR, Monaghan MJ; UK TAVI Steering Committee and the National Institute for Cardiovascular Outcome Research.

Heart. 2018 Oct;104(19):1621-1628. doi: 10.1136/heartjnl-2017-312559. Epub 2018 Mar 29.

PMID:
29599379
9.

An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.

Ling R, Rush A, Carter C, Carpenter J, Watson PH, Byrne JA, Searles A.

Biopreserv Biobank. 2018 Feb;16(1):53-58. doi: 10.1089/bio.2017.0095. Epub 2017 Dec 7.

PMID:
29215912
10.

Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.

Murray J, Valli E, Yu DMT, Truong AM, Gifford AJ, Eden GL, Gamble LD, Hanssen KM, Flemming CL, Tan A, Tivnan A, Allan S, Saletta F, Cheung L, Ruhle M, Schuetz JD, Henderson MJ, Byrne JA, Norris MD, Haber M, Fletcher JI.

Eur J Cancer. 2017 Sep;83:132-141. doi: 10.1016/j.ejca.2017.06.024. Epub 2017 Jul 20.

11.

Electrochemical Enhancement of Photocatalytic Disinfection on Aligned TiO₂ and Nitrogen Doped TiO₂ Nanotubes.

Pablos C, Marugán J, van Grieken R, Dunlop PSM, Hamilton JWJ, Dionysiou DD, Byrne JA.

Molecules. 2017 Apr 28;22(5). pii: E704. doi: 10.3390/molecules22050704.

12.

Acute acinar pancreatitis blocks vesicle-associated membrane protein 8 (VAMP8)-dependent secretion, resulting in intracellular trypsin accumulation.

Messenger SW, Jones EK, Holthaus CL, Thomas DDH, Cooley MM, Byrne JA, Mareninova OA, Gukovskaya AS, Groblewski GE.

J Biol Chem. 2017 May 12;292(19):7828-7839. doi: 10.1074/jbc.M117.781815. Epub 2017 Feb 27.

13.

Use of Selected Scavengers for the Determination of NF-TiO2 Reactive Oxygen Species during the Degradation of Microcystin-LR under Visible Light Irradiation.

Pelaez M, Falaras P, Likodimos V, O'Shea K, de la Cruz AA, Dunlop PSM, Byrne JA, Dionysiou DD.

J Mol Catal A Chem. 2016 Dec 15;425(0):183-189. doi: 10.1016/j.molcata.2016.09.035.

14.

An HPLC-UV method for determining plasma dimethylacetamide concentrations in patients receiving intravenous busulfan.

Cendana M, Lee S, Upadhyay PJ, Byrne JA, Shaw PJ, Earl J, Nath CE.

Biomed Chromatogr. 2017 Jul;31(7). doi: 10.1002/bmc.3906. Epub 2016 Dec 21.

PMID:
27925250
15.

Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells.

Lee PC, Truong B, Vega-Crespo A, Gilmore WB, Hermann K, Angarita SA, Tang JK, Chang KM, Wininger AE, Lam AK, Schoenberg BE, Cederbaum SD, Pyle AD, Byrne JA, Lipshutz GS.

Mol Ther Nucleic Acids. 2016 Nov 29;5(11):e394. doi: 10.1038/mtna.2016.98.

16.

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.

Liu PY, Sokolowski N, Guo ST, Siddiqi F, Atmadibrata B, Telfer TJ, Sun Y, Zhang L, Yu D, Mccarroll J, Liu B, Yang RH, Guo XY, Tee AE, Itoh K, Wang J, Kavallaris M, Haber M, Norris MD, Cheung BB, Byrne JA, Ziegler DS, Marshall GM, Dinger ME, Codd R, Zhang XD, Liu T.

Oncotarget. 2016 Nov 29;7(48):79217-79232. doi: 10.18632/oncotarget.12640.

17.

Dropping in on the lipid droplet- tumor protein D52 (TPD52) as a new regulator and resident protein.

Chen Y, Frost S, Byrne JA.

Adipocyte. 2016 Mar 22;5(3):326-32. doi: 10.1080/21623945.2016.1148835. eCollection 2016 Jul-Sep.

18.

Improving the peer review of narrative literature reviews.

Byrne JA.

Res Integr Peer Rev. 2016 Sep 4;1:12. doi: 10.1186/s41073-016-0019-2. eCollection 2016.

19.

Investigating the functionality of an OCT4-short response element in human induced pluripotent stem cells.

Vega-Crespo A, Truong B, Hermann KJ, Awe JP, Chang KM, Lee PC, Schoenberg BE, Wu L, Byrne JA, Lipshutz GS.

Mol Ther Methods Clin Dev. 2016 Jul 20;3:16050. doi: 10.1038/mtm.2016.50. eCollection 2016.

20.

Genetic causes of cancer predisposition in children and adolescents.

Saletta F, Dalla Pozza L, Byrne JA.

Transl Pediatr. 2015 Apr;4(2):67-75. doi: 10.3978/j.issn.2224-4336.2015.04.08. Review.

21.

Quality and reporting practices in an Australian cancer biobank cohort.

Rush A, Byrne JA.

Clin Biochem. 2016 Apr;49(6):492-497. doi: 10.1016/j.clinbiochem.2015.12.007. Epub 2015 Dec 17.

PMID:
26708174
22.

A critical analysis of cancer biobank practices in relation to biospecimen quality.

Rush A, Spring K, Byrne JA.

Biophys Rev. 2015 Dec;7(4):369-378. doi: 10.1007/s12551-015-0178-2. Epub 2015 Oct 22. Review.

23.

Development and Validation of a High Pressure Liquid Chromatography-UV Method for the Determination of Treosulfan and Its Epoxy Metabolites in Human Plasma and Its Application in Pharmacokinetic Studies.

Koyyalamudi SR, Kuzhiumparambil U, Nath CE, Byrne JA, Fraser CJ, O'Brien TA, Earl JW, Shaw PJ.

J Chromatogr Sci. 2016 Mar;54(3):326-33. doi: 10.1093/chromsci/bmv145. Epub 2015 Oct 3.

PMID:
26433392
24.

New Insights into the Mechanism of Visible Light Photocatalysis.

Banerjee S, Pillai SC, Falaras P, O'Shea KE, Byrne JA, Dionysiou DD.

J Phys Chem Lett. 2014 Aug 7;5(15):2543-54. doi: 10.1021/jz501030x. Epub 2014 Jul 18.

PMID:
26277942
25.

TPD52 expression increases neutral lipid storage within cultured cells.

Kamili A, Roslan N, Frost S, Cantrill LC, Wang D, Della-Franca A, Bright RK, Groblewski GE, Straub BK, Hoy AJ, Chen Y, Byrne JA.

J Cell Sci. 2015 Sep 1;128(17):3223-38. doi: 10.1242/jcs.167692. Epub 2015 Jul 16.

26.

Biobank classification in an Australian setting.

Rush A, Christiansen JH, Farrell JP, Goode SM, Scott RJ, Spring KJ, Byrne JA.

Biopreserv Biobank. 2015 Jun;13(3):212-8. doi: 10.1089/bio.2015.0007.

PMID:
26035012
27.

Neuroblastoma, body mass index, and survival: a retrospective analysis.

Small AG, Thwe le M, Byrne JA, Lau L, Chan A, Craig ME, Cowell CT, Garnett SP.

Medicine (Baltimore). 2015 Apr;94(14):e713. doi: 10.1097/MD.0000000000000713.

28.

A review of heterogeneous photocatalysis for water and surface disinfection.

Byrne JA, Dunlop PS, Hamilton JW, Fernández-Ibáñez P, Polo-López I, Sharma PK, Vennard AS.

Molecules. 2015 Mar 30;20(4):5574-615. doi: 10.3390/molecules20045574. Review.

29.

Putative immunogenicity expression profiling using human pluripotent stem cells and derivatives.

Awe JP, Gschweng EH, Vega-Crespo A, Voutila J, Williamson MH, Truong B, Kohn DB, Kasahara N, Byrne JA.

Stem Cells Transl Med. 2015 Feb;4(2):136-45. doi: 10.5966/sctm.2014-0117. Epub 2015 Jan 9.

30.
31.

Overexpressed oncogenic tumor-self antigens.

Bright RK, Bright JD, Byrne JA.

Hum Vaccin Immunother. 2014;10(11):3297-305. doi: 10.4161/hv.29475. Review.

32.

Developing neural stem cell-based treatments for neurodegenerative diseases.

Byrne JA.

Stem Cell Res Ther. 2014 May 30;5(3):72. doi: 10.1186/scrt461.

33.

Informal urban green-space: comparison of quantity and characteristics in Brisbane, Australia and Sapporo, Japan.

Rupprecht CD, Byrne JA.

PLoS One. 2014 Jun 18;9(6):e99784. doi: 10.1371/journal.pone.0099784. eCollection 2014.

34.

Molecular profiling of childhood cancer: Biomarkers and novel therapies.

Saletta F, Wadham C, Ziegler DS, Marshall GM, Haber M, McCowage G, Norris MD, Byrne JA.

BBA Clin. 2014 Jun 28;1:59-77. doi: 10.1016/j.bbacli.2014.06.003. eCollection 2014 Jun. Review.

35.

Investigation of the inhibitory effects of TiO(2) on the β-amyloid peptide aggregation.

Ahmed MH, Byrne JA, Keyes TE.

Mater Sci Eng C Mater Biol Appl. 2014 Jun 1;39:227-34. doi: 10.1016/j.msec.2014.03.011. Epub 2014 Mar 12.

PMID:
24863220
36.

Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?

Byrne JA, Frost S, Chen Y, Bright RK.

Tumour Biol. 2014 Aug;35(8):7369-82. doi: 10.1007/s13277-014-2006-x. Epub 2014 May 6. Review.

PMID:
24798974
37.

Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening.

Shahheydari H, Frost S, Smith BJ, Groblewski GE, Chen Y, Byrne JA.

Mol Biol Rep. 2014 Jul;41(7):4565-72. doi: 10.1007/s11033-014-3327-y. Epub 2014 Mar 7.

38.

Color me healthy: food diversity in school community gardens in two rapidly urbanising Australian cities.

Guitart DA, Pickering CM, Byrne JA.

Health Place. 2014 Mar;26:110-7. doi: 10.1016/j.healthplace.2013.12.014. Epub 2013 Dec 31.

PMID:
24434081
39.

Proteomic screening of glutamatergic mouse brain synaptosomes isolated by fluorescence activated sorting.

Biesemann C, Grønborg M, Luquet E, Wichert SP, Bernard V, Bungers SR, Cooper B, Varoqueaux F, Li L, Byrne JA, Urlaub H, Jahn O, Brose N, Herzog E.

EMBO J. 2014 Jan 13;33(2):157-70. doi: 10.1002/embj.201386120. Epub 2014 Jan 10.

40.

Germline stem cells: toward the regeneration of spermatogenesis.

Valli H, Phillips BT, Shetty G, Byrne JA, Clark AT, Meistrich ML, Orwig KE.

Fertil Steril. 2014 Jan;101(1):3-13. doi: 10.1016/j.fertnstert.2013.10.052. Epub 2013 Dec 5. Review.

41.

Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen.

Bright JD, Schultz HN, Byrne JA, Bright RK.

Oncoimmunology. 2013 Jul 1;2(7):e25049. Epub 2013 May 21.

42.

Tumor protein D52 represents a negative regulator of ATM protein levels.

Chen Y, Kamili A, Hardy JR, Groblewski GE, Khanna KK, Byrne JA.

Cell Cycle. 2013 Sep 15;12(18):3083-97. doi: 10.4161/cc.26146. Epub 2013 Aug 21.

43.

The association between TNF-α and insulin resistance in euglycemic women.

Walsh JM, McGowan CA, Byrne JA, Rath A, McAuliffe FM.

Cytokine. 2013 Oct;64(1):208-12. doi: 10.1016/j.cyto.2013.07.001. Epub 2013 Aug 14.

PMID:
23953853
44.

Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.

Kasten J, Hu C, Bhargava R, Park H, Tai D, Byrne JA, Marescau B, De Deyn PP, Schlichting L, Grody WW, Cederbaum SD, Lipshutz GS.

Mol Genet Metab. 2013 Nov;110(3):222-30. doi: 10.1016/j.ymgme.2013.06.020. Epub 2013 Jul 6.

45.

Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status.

Awe JP, Lee PC, Ramathal C, Vega-Crespo A, Durruthy-Durruthy J, Cooper A, Karumbayaram S, Lowry WE, Clark AT, Zack JA, Sebastiano V, Kohn DB, Pyle AD, Martin MG, Lipshutz GS, Phelps PE, Pera RA, Byrne JA.

Stem Cell Res Ther. 2013 Jul 26;4(4):87. doi: 10.1186/scrt246.

46.

Tumor protein D52 controls trafficking of an apical endolysosomal secretory pathway in pancreatic acinar cells.

Messenger SW, Thomas DD, Falkowski MA, Byrne JA, Gorelick FS, Groblewski GE.

Am J Physiol Gastrointest Liver Physiol. 2013 Sep 15;305(6):G439-52. doi: 10.1152/ajpgi.00143.2013. Epub 2013 Jul 18.

47.

TPD52 represents a survival factor in ERBB2-amplified breast cancer cells.

Roslan N, Bièche I, Bright RK, Lidereau R, Chen Y, Byrne JA.

Mol Carcinog. 2014 Oct;53(10):807-19. doi: 10.1002/mc.22038. Epub 2013 May 9.

PMID:
23661506
48.

Identifying candidate oocyte reprogramming factors using cross-species global transcriptional analysis.

Awe JP, Byrne JA.

Cell Reprogram. 2013 Apr;15(2):126-33. doi: 10.1089/cell.2012.0060. Epub 2013 Mar 4.

49.

BAY11 enhances OCT4 synthetic mRNA expression in adult human skin cells.

Awe JP, Crespo AV, Li Y, Kiledjian M, Byrne JA.

Stem Cell Res Ther. 2013 Feb 6;4(1):15. doi: 10.1186/scrt163.

50.

ATP8B1 gene expression is driven by a housekeeping-like promoter independent of bile acids and farnesoid X receptor.

Cebecauerová D, Strautnieks SS, Byrne JA, Jirsa M, Thompson RJ.

PLoS One. 2012;7(12):e51650. doi: 10.1371/journal.pone.0051650. Epub 2012 Dec 10.

Supplemental Content

Loading ...
Support Center